TRDA SCHEDULE 13D/A: SEC filing
MPM BioImpact affiliates
Filed with the SEC on · accession 0001231919-26-001160
TRDA filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Sep 10, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -9.7% by the first close after the filing.
Summary of the filing
MPM BioImpact affiliates filed an amendment to their Schedule 13D regarding their ownership position in Entrada Therapeutics, listing the general partners/members of the filing entities.
Key details
How TRDA stock reacted
Close before
$7.11
Sep 9, 2026
First close after
-9.70%
$6.42
5 trading days
-3.09%
$6.89
Since filing
-36.01%
$4.55
✦ Ask GOAX AI about this filing — what it means for TRDA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TRDA?
Click hereFrequently asked questions
What did TRDA file with the SEC on Sep 10, 2026?
TRDA filed a SCHEDULE 13D/A (SEC filing). MPM BioImpact affiliates filed an amendment to their Schedule 13D regarding their ownership position in Entrada Therapeutics, listing the general partners/members of the filing entities.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did TRDA stock react to this filing?
TRDA closed at $7.11 before the filing and $6.42 on Sep 10, 2026 (-9.70%). Five trading days later: $6.89 (-3.09%).
Other TRDA SEC filings
Get alerts when TRDA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days